Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-20-017414
Filing Date
2020-12-11
Accepted
2020-12-11 17:01:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 a2020decs-3document.htm S-3 257927
2 EX-5.1 a2020decs-3exhibit5.htm EX-5.1 41847
3 EX-23.1 a2020decs-3exhibit231.htm EX-23.1 3205
4 image_01a.jpg GRAPHIC 278098
  Complete submission text file 0001628280-20-017414.txt   687079
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251308 | Film No.: 201384260
SIC: 2834 Pharmaceutical Preparations